| 36.6906 -0.393 (-1.06%) | 09-04 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 44.26 | 1-year : | 51.7 |
| Resists | First : | 37.9 | Second : | 44.26 |
| Pivot price | 36.99  |
|||
| Supports | First : | 35.82 | Second : | 34.54 |
| MAs | MA(5) : | 36.82 |
MA(20) : | 36.71 |
| MA(100) : | 34.79 |
MA(250) : | 33.43 |
|
| MACD | MACD : | 0.3 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 60.1 |
D(3) : | 58.7 |
| RSI | RSI(14): 52.1 |
|||
| 52-week | High : | 37.9 | Low : | 28.51 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ MEDX ] has closed above bottom band by 35.7%. Bollinger Bands are 13% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 36.84 - 37.09 | 37.09 - 37.29 |
| Low: | 36.04 - 36.28 | 36.28 - 36.49 |
| Close: | 36.33 - 36.73 | 36.73 - 37.06 |
Listed Funds Trust - Horizon Kinetics Medical ETF is an exchange traded fund launched by Listed Funds Trust. The fund is managed by Horizon Kinetics Asset Management LLC. The fund invests in public equity markets of global region. It invests in stocks of companies operating across healthcare, healthcare equipment and services, healthcare equipment and supplies, healthcare equipment, medical equipment, surgical and laboratory sterilizers, healthcare providers and services, health care services, medical laboratory services, medical research laboratory services, pharmaceuticals, biotechnology and life science sectors. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to benchmark the performance of its portfolio against the S&P 500 TR Index. Listed Funds Trust - Horizon Kinetics Medical ETF was formed on September 30, 1999 and is domiciled in the United States.
Fri, 04 Sep 2026
Trading Systems Reacting to (MEDX) Volatility - Stock Traders Daily
Thu, 08 Jan 2026
DCOY Stock Price and Chart — NASDAQ:DCOY - TradingView
Fri, 08 Aug 2025
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data - TradingView
Tue, 22 Jul 2025
ETFs Investing in Bicycle Therapeutics Plc Sponsored ADR Stocks - TradingView
Mon, 12 Aug 2024
5 ETFs to Make the Most of Eli Lilly's Strength - Yahoo Finance
Wed, 01 May 2024
ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|